Search Media Items

Hoja informativa que resume los estudios sobre los efectos para la salud de la exposición al humo de tabaco en el ambiente.

Information about why clinical trials may end early.

TMIST es un estudio aleatorizado de exámenes de detección de cáncer de seno que compara dos tipos de mamografía digital aprobados por la FDA, la mamografía digital (2-D) convencional con una tecnología más nueva llamada mamografía de tomosíntesis (3-D).

Scientific review ensures that studies are based on sound science, which contributes to the safety of clinical trial participants. Learn about the role of Institutional Review Boards (IRBs), Data and Safety Monitoring Boards (DSMBs), and government agenci

Tumor DNA sequencing (also called genetic profiling or genetic testing) is a test to identify DNA changes in a patient’s cancer. In some cases, this information can help determine a treatment plan.

As NCI's central scientific strategy office, CRS collaborates with the institute's divisions, offices, and centers to identify research opportunities to advance NCI's vision for the future of cancer research.

TMIST is a randomized breast screening trial that compares two Food and Drug Administration (FDA)-approved types of digital mammography, standard digital mammography (2-D) with a newer technology called tomosynthesis mammography (3-D).

Information about the ways in which clinical trial participants are protected before and during the conduct of a study.

Information about government health programs that may cover some costs associated with clinical trial participation.

Most health insurance plans are required to cover routine patient care costs in clinical trials under certain conditions. Learn about the conditions that insurance plans take into account and how to work with your insurance company.